What Is Hereditary Angioedema? Symptoms and Current Treatment

Hereditary angioedema (HAE) is a rare genetic disorder with hereditary transmission , making it an important concern for healthcare professionals and the public. It is characterized by sudden swelling and can lead to serious health problems. It affects approximately one in 50,000 people. This article reviews what HAE is, its inheritance, brief history, symptoms and current treatments.

Although many specialists contribute to diagnosis and treatment, allergists and immunologists, dermatologists and genetic counselors play particularly prominent roles.

What Is Hereditary Angioedema?

Hereditary angioedema is a genetic disorder characterized by sudden swelling, caused by deficiency or dysfunction of the C1 inhibitor protein.

This causes an uncontrolled inflammatory reaction in the body, which can lead to edema (swelling) in the skin, intestines and airways.

How Does HAE Develop?

The C1 inhibitor protein controls the complement system, which is part of the immune system. The complement system is involved in defense against infection and inflammation .

C1 Inhibitor Deficiency or Dysfunction

When C1 inhibitor is deficient or dysfunctional, the complement system becomes activated without control. This can cause excessive inflammation and fluid accumulation in certain parts of the body.

How HAE Develops

1. Uncontrolled Complement System Activation: C1 inhibitor deficiency causes uncontrolled activation of the C1 complex.
2. Increased Bradykinin: Uncontrolled activation leads to overproduction of a peptide called bradykinin. Bradykinin causes blood vessels to widen and fluid to leak into tissues.
3. Development of Swelling: Under the effects of bradykinin, fluid accumulates in the skin, intestines and airways, causing swelling in these areas.
4. Potential Threat to Life: Swelling in the airways can cause suffocation and become life-threatening.

In summary, deficiency or dysfunction of the C1 inhibitor protein is the fundamental pathophysiological mechanism of HAE. It causes uncontrolled complement system activation and swelling. Treatment generally targets this mechanism, for example through C1 inhibitor concentrates, to control symptoms and prevent attacks.

This complex mechanism requires a specialist approach to HAE diagnosis and treatment. Because each patient's situation may differ, treatment plans should be tailored to individual needs.

Symptoms

Symptoms of HAE include:

• Skin Swelling: Sudden swelling in the hands, feet, face and genital area.
• Intestinal Swelling: Abdominal pain, vomiting and diarrhea.
• Airway Swelling: Difficulty breathing and swelling in the throat.

Inheritance of Hereditary Angioedema

Hereditary angioedema usually follows an autosomal dominant inheritance pattern. This means that a single copy of the disease-causing gene, inherited from either parent, is sufficient to cause the condition. The gene encoding the C1 inhibitor protein is SERPING1 gene.

Autosomal Dominant Inheritance

• A Parent Who Is a Carrier: If one parent carries HAE, their children have a 50 percent chance of carrying the condition.
• If Both Parents Are Carriers: If both parents carry the condition, calculating the probability that their children will carry it may be more complex.
• Sporadic Mutations: Rarely, HAE can also develop from a new gene mutation arising during life. In this situation, there may be no previous family history.

Inheritance Unrelated to Sex

HAE is not a sex-linked condition, meaning it can occur equally in men and women. Autosomal dominant inheritance is unrelated to the X or Y chromosomes, so sex does not determine transmission.

Does Every Carrier Also Have the Disease?

In hereditary angioedema (HAE), carriers are generally people who have the condition and show symptoms. However, this is not always the case. Important points include:

• Genetic Variability: HAE symptoms can vary among carriers. Some people may have milder symptoms, while others have more severe symptoms.
• Penetrance: Autosomal dominant disorders involve a concept known as gene "penetrance." Penetrance describes the extent to which a gene produces symptoms. In HAE, penetrance is generally high, meaning most people carrying the gene show symptoms. However, in some cases a person carrying the gene may have no symptoms or only very mild symptoms.
• New Mutations and Other Factors: In addition to genetic factors, environmental influences and lifestyle may affect HAE symptoms, leading to variations in symptom severity and frequency.
• Diagnosis and Assessment: Early diagnosis and accurate assessment of HAE are critical for symptom management and treatment planning. Genetic counseling can help family members understand their risks and potential symptoms.

In conclusion, anyone carrying the HAE gene may develop symptoms, but their severity and frequency vary between individuals. Genetic counseling and assessment by a specialist healthcare team can therefore help clarify each person's situation.

History

1. First Description: HAE was first described in 1888 by the German physiologist and dermatologist Heinrich Quincke. He called it "acute circumscribed edema" and described swelling caused by fluid accumulation in the tissue beneath the skin.
2. Naming: In 1917, Sir William Osler recognized the familial nature of the condition and added the term "hereditary," changing its name to "hereditary angioedema."
3. C1 Inhibitor Deficiency: In 1963, Virginia Donaldson discovered that HAE was associated with deficiency or dysfunction of the C1 inhibitor protein. This was an important step in understanding the condition's pathophysiology.
4. Genetic Basis: In the late 1980s, the genetic basis of HAE became better understood. Mutations in SERPING1 cause deficiency or dysfunction of the C1 inhibitor protein.
5. Diagnostic Methods: During the second half of the 20th century, diagnostic methods improved, allowing more accurate diagnosis of HAE.
6. Treatment Methods: In the early 2000s, specific treatments for HAE began to be developed, substantially improving patients' quality of life.

The discovery and understanding of hereditary angioedema represent a complex and fascinating area of medical science. These advances have contributed to a broader understanding of genetic disorders and helped develop modern medical treatments and diagnostic methods.

Diagnosis

Diagnosis of hereditary angioedema (HAE) usually involves several steps and can sometimes be complex because its symptoms may resemble other allergic reactions. The diagnostic process includes:

1. Clinical Assessment

• Patient History: Information is collected about the patient's personal and family history, previous attacks, and the duration and severity of symptoms.
• Physical Examination: A physician may perform a physical examination to assess swelling and other symptoms.

2. Laboratory Tests

• C1 Inhibitor Level and Function: Blood tests measure the level and function of the C1 inhibitor protein. In patients with HAE, this protein may be deficient or dysfunctional.
• C4 Complement Level: C4 levels are generally low, which can support the diagnosis.
• C1q Level: The C1q level should be normal; low levels may indicate another complement disorder.

3. Genetic Testing

• SERPING1 Gene Testing: The most common form of HAE is associated with a mutation in SERPING1. Genetic testing can confirm the presence of this mutation.

4. Differential Diagnosis

• Excluding Other Conditions: HAE symptoms can be confused with allergic angioedema or other medical conditions. These possibilities must be excluded.

5. Assessment of Family Members

• Family Testing: Because HAE is a genetic disorder, assessment of family members may also be important.

In conclusion, HAE diagnosis combines clinical assessment, laboratory tests and genetic testing when necessary. A specialist healthcare team should make the diagnosis, because early and accurate recognition of this condition is critical to effective treatment and management.

The process may vary according to the patient's symptoms, family history and other individual factors, so each patient's situation may be unique.

Conclusion

Hereditary angioedema can be a serious and potentially life-threatening condition. Early diagnosis and effective treatment can substantially improve patients' quality of life.

Current HAE management should be tailored to individual needs and disease severity. A specialist healthcare team should organize treatment, taking account of factors such as the patient's lifestyle and the frequency and severity of attacks.

This overview covers the main aspects of current HAE management. Please let me know if you would like information about a more specific situation or further details!